Global Group B Streptococcus (GBS) Infection Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Group B Streptococcus (GBS) Infection Treatment Industry Forecast” looks at past sales and reviews total world Group B Streptococcus (GBS) Infection Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Group B Streptococcus (GBS) Infection Treatment sales for 2023 through 2029. With Group B Streptococcus (GBS) Infection Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Group B Streptococcus (GBS) Infection Treatment industry.
This Insight Report provides a comprehensive analysis of the global Group B Streptococcus (GBS) Infection Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Group B Streptococcus (GBS) Infection Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Group B Streptococcus (GBS) Infection Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Group B Streptococcus (GBS) Infection Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Group B Streptococcus (GBS) Infection Treatment.
The global Group B Streptococcus (GBS) Infection Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Group B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Group B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Group B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Group B Streptococcus (GBS) Infection Treatment players cover Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Group B Streptococcus (GBS) Infection Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Group B Streptococcus (GBS) Infection Treatment Industry Forecast” looks at past sales and reviews total world Group B Streptococcus (GBS) Infection Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Group B Streptococcus (GBS) Infection Treatment sales for 2023 through 2029. With Group B Streptococcus (GBS) Infection Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Group B Streptococcus (GBS) Infection Treatment industry.
This Insight Report provides a comprehensive analysis of the global Group B Streptococcus (GBS) Infection Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Group B Streptococcus (GBS) Infection Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Group B Streptococcus (GBS) Infection Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Group B Streptococcus (GBS) Infection Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Group B Streptococcus (GBS) Infection Treatment.
The global Group B Streptococcus (GBS) Infection Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Group B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Group B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Group B Streptococcus (GBS) Infection Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Group B Streptococcus (GBS) Infection Treatment players cover Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Group B Streptococcus (GBS) Infection Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Prenatal-onset Gbs Disease
- Early-onset Gbs Disease
- Late-onset Gbs Disease
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- Alopexx Enterprises, LLC
- Wellstat Vaccines LLC
- Minervax ApS
- Novartis
- GlaxoSmithKline
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2029
2.1.2 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Group B Streptococcus (GBS) Infection Treatment Segment by Type
2.2.1 Prenatal-onset Gbs Disease
2.2.2 Early-onset Gbs Disease
2.2.3 Late-onset Gbs Disease
2.3 Group B Streptococcus (GBS) Infection Treatment Market Size by Type
2.3.1 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
2.4 Group B Streptococcus (GBS) Infection Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Group B Streptococcus (GBS) Infection Treatment Market Size by Application
2.5.1 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
3 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SIZE BY PLAYER
3.1 Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Players
3.1.1 Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023)
3.1.2 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT BY REGIONS
4.1 Group B Streptococcus (GBS) Infection Treatment Market Size by Regions (2018-2023)
4.2 Americas Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.3 APAC Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.4 Europe Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
5.2 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
5.3 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023)
6.2 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
6.3 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Group B Streptococcus (GBS) Infection Treatment by Country (2018-2023)
7.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
7.3 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment by Region (2018-2023)
8.2 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET FORECAST
10.1 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Regions (2024-2029)
10.1.1 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.3 APAC Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.4 Europe Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Forecast
10.2 Americas Group B Streptococcus (GBS) Infection Treatment Forecast by Country (2024-2029)
10.2.1 United States Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.2 Canada Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.3 Mexico Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.4 Brazil Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3 APAC Group B Streptococcus (GBS) Infection Treatment Forecast by Region (2024-2029)
10.3.1 China Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.2 Japan Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.3 Korea Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.4 Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.5 India Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.6 Australia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4 Europe Group B Streptococcus (GBS) Infection Treatment Forecast by Country (2024-2029)
10.4.1 Germany Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.2 France Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.3 UK Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.4 Italy Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.5 Russia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.2 South Africa Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.3 Israel Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.4 Turkey Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.5 GCC Countries Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.6 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Type (2024-2029)
10.7 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offered
11.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Alopexx Enterprises, LLC
11.2.1 Alopexx Enterprises, LLC Company Information
11.2.2 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
11.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Alopexx Enterprises, LLC Main Business Overview
11.2.5 Alopexx Enterprises, LLC Latest Developments
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Information
11.3.2 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
11.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Wellstat Vaccines LLC Main Business Overview
11.3.5 Wellstat Vaccines LLC Latest Developments
11.4 Minervax ApS
11.4.1 Minervax ApS Company Information
11.4.2 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offered
11.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Minervax ApS Main Business Overview
11.4.5 Minervax ApS Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Group B Streptococcus (GBS) Infection Treatment Product Offered
11.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offered
11.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2029
2.1.2 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Group B Streptococcus (GBS) Infection Treatment Segment by Type
2.2.1 Prenatal-onset Gbs Disease
2.2.2 Early-onset Gbs Disease
2.2.3 Late-onset Gbs Disease
2.3 Group B Streptococcus (GBS) Infection Treatment Market Size by Type
2.3.1 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
2.4 Group B Streptococcus (GBS) Infection Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Group B Streptococcus (GBS) Infection Treatment Market Size by Application
2.5.1 Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
3 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET SIZE BY PLAYER
3.1 Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Players
3.1.1 Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023)
3.1.2 Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT BY REGIONS
4.1 Group B Streptococcus (GBS) Infection Treatment Market Size by Regions (2018-2023)
4.2 Americas Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.3 APAC Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.4 Europe Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023)
5.2 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
5.3 Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023)
6.2 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
6.3 APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Group B Streptococcus (GBS) Infection Treatment by Country (2018-2023)
7.2 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
7.3 Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment by Region (2018-2023)
8.2 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT MARKET FORECAST
10.1 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Regions (2024-2029)
10.1.1 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.3 APAC Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.4 Europe Group B Streptococcus (GBS) Infection Treatment Forecast
10.1.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Forecast
10.2 Americas Group B Streptococcus (GBS) Infection Treatment Forecast by Country (2024-2029)
10.2.1 United States Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.2 Canada Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.3 Mexico Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.2.4 Brazil Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3 APAC Group B Streptococcus (GBS) Infection Treatment Forecast by Region (2024-2029)
10.3.1 China Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.2 Japan Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.3 Korea Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.4 Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.5 India Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.3.6 Australia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4 Europe Group B Streptococcus (GBS) Infection Treatment Forecast by Country (2024-2029)
10.4.1 Germany Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.2 France Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.3 UK Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.4 Italy Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.4.5 Russia Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5 Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.2 South Africa Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.3 Israel Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.4 Turkey Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.5.5 GCC Countries Group B Streptococcus (GBS) Infection Treatment Market Forecast
10.6 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Type (2024-2029)
10.7 Global Group B Streptococcus (GBS) Infection Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Information
11.1.2 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offered
11.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc. Latest Developments
11.2 Alopexx Enterprises, LLC
11.2.1 Alopexx Enterprises, LLC Company Information
11.2.2 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
11.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Alopexx Enterprises, LLC Main Business Overview
11.2.5 Alopexx Enterprises, LLC Latest Developments
11.3 Wellstat Vaccines LLC
11.3.1 Wellstat Vaccines LLC Company Information
11.3.2 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
11.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Wellstat Vaccines LLC Main Business Overview
11.3.5 Wellstat Vaccines LLC Latest Developments
11.4 Minervax ApS
11.4.1 Minervax ApS Company Information
11.4.2 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offered
11.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Minervax ApS Main Business Overview
11.4.5 Minervax ApS Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Group B Streptococcus (GBS) Infection Treatment Product Offered
11.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offered
11.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Prenatal-onset Gbs Disease
Table 3. Major Players of Early-onset Gbs Disease
Table 4. Major Players of Late-onset Gbs Disease
Table 5. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 8. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player (2018-2023)
Table 13. Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
Table 14. Group B Streptococcus (GBS) Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Group B Streptococcus (GBS) Infection Treatment
Table 46. Key Market Challenges & Risks of Group B Streptococcus (GBS) Infection Treatment
Table 47. Key Industry Trends of Group B Streptococcus (GBS) Infection Treatment
Table 48. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Inc. Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 53. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 54. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Inc. Main Business
Table 56. Pfizer Inc. Latest Developments
Table 57. Alopexx Enterprises, LLC Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 58. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 59. Alopexx Enterprises, LLC Main Business
Table 60. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Alopexx Enterprises, LLC Latest Developments
Table 62. Wellstat Vaccines LLC Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 63. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 64. Wellstat Vaccines LLC Main Business
Table 65. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Wellstat Vaccines LLC Latest Developments
Table 67. Minervax ApS Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 68. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 69. Minervax ApS Main Business
Table 70. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Minervax ApS Latest Developments
Table 72. Novartis Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 73. Novartis Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 74. Novartis Main Business
Table 75. Novartis Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Novartis Latest Developments
Table 77. GlaxoSmithKline Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 78. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. GlaxoSmithKline Latest Developments
Table 1. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Prenatal-onset Gbs Disease
Table 3. Major Players of Early-onset Gbs Disease
Table 4. Major Players of Late-onset Gbs Disease
Table 5. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 8. Group B Streptococcus (GBS) Infection Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 11. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player (2018-2023)
Table 13. Group B Streptococcus (GBS) Infection Treatment Key Players Head office and Products Offered
Table 14. Group B Streptococcus (GBS) Infection Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Group B Streptococcus (GBS) Infection Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2018-2023)
Table 19. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2018-2023)
Table 23. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 25. Americas Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 27. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Table 29. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 31. APAC Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 33. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country (2018-2023)
Table 35. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 37. Europe Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Group B Streptococcus (GBS) Infection Treatment
Table 46. Key Market Challenges & Risks of Group B Streptococcus (GBS) Infection Treatment
Table 47. Key Industry Trends of Group B Streptococcus (GBS) Infection Treatment
Table 48. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Group B Streptococcus (GBS) Infection Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Pfizer Inc. Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 53. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 54. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Pfizer Inc. Main Business
Table 56. Pfizer Inc. Latest Developments
Table 57. Alopexx Enterprises, LLC Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 58. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 59. Alopexx Enterprises, LLC Main Business
Table 60. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Alopexx Enterprises, LLC Latest Developments
Table 62. Wellstat Vaccines LLC Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 63. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 64. Wellstat Vaccines LLC Main Business
Table 65. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Wellstat Vaccines LLC Latest Developments
Table 67. Minervax ApS Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 68. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 69. Minervax ApS Main Business
Table 70. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Minervax ApS Latest Developments
Table 72. Novartis Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 73. Novartis Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 74. Novartis Main Business
Table 75. Novartis Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Novartis Latest Developments
Table 77. GlaxoSmithKline Details, Company Type, Group B Streptococcus (GBS) Infection Treatment Area Served and Its Competitors
Table 78. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offered
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Group B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Group B Streptococcus (GBS) Infection Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country/Region (2022)
Figure 8. Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2022
Figure 10. Group B Streptococcus (GBS) Infection Treatment in Hospital Pharmacies
Figure 11. Global Group B Streptococcus (GBS) Infection Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Group B Streptococcus (GBS) Infection Treatment in Retail Pharmacies
Figure 13. Global Group B Streptococcus (GBS) Infection Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Group B Streptococcus (GBS) Infection Treatment in Online Pharmacies
Figure 15. Global Group B Streptococcus (GBS) Infection Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2022
Figure 17. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player in 2022
Figure 18. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Group B Streptococcus (GBS) Infection Treatment Value Market Share by Country in 2022
Figure 24. United States Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2022
Figure 31. China Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Group B Streptococcus (GBS) Infection Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Group B Streptococcus (GBS) Infection Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country/Region (2022)
Figure 8. Group B Streptococcus (GBS) Infection Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2022
Figure 10. Group B Streptococcus (GBS) Infection Treatment in Hospital Pharmacies
Figure 11. Global Group B Streptococcus (GBS) Infection Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Group B Streptococcus (GBS) Infection Treatment in Retail Pharmacies
Figure 13. Global Group B Streptococcus (GBS) Infection Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Group B Streptococcus (GBS) Infection Treatment in Online Pharmacies
Figure 15. Global Group B Streptococcus (GBS) Infection Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2022
Figure 17. Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share by Player in 2022
Figure 18. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Group B Streptococcus (GBS) Infection Treatment Value Market Share by Country in 2022
Figure 24. United States Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application in 2022
Figure 31. China Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Group B Streptococcus (GBS) Infection Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Group B Streptococcus (GBS) Infection Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Group B Streptococcus (GBS) Infection Treatment Market Size Market Share Forecast by Application (2024-2029)
